Increased monocyte count and red cell distribution width represent negative prognostic markers in patients with Idiopathic Pulmonary Fibrosis.

T. Karampitsakos (Athens, Greece), S. Torrisi (Heidelberg, Germany), K. Antoniou (Heraklion, Greece), E. Bouros (Athens, Greece), I. Korbila (Athens, Greece), E. Manali (Athens, Greece), E. Vasarmidi (Heraklion, Greece), D. Papakosta (Thessaloniki, Greece), K. Domvri (Thessaloniki, Greece), Z. Daniil (Larissa, Greece), I. Dimeas (Larissa, Greece), P. Kirgou (Larissa, Greece), I. Papanikolaou (Corfu, Greece), E. Bibaki (Heraklion, Greece), K. Markopoulou (Thessaloniki, Greece), G. Kounti (Thessaloniki, Greece), E. Tsapakidou (Thessaloniki, Greece), E. Papadopoulou (Thessaloniki, Greece), S. Papiris (Athens, Greece), D. Bouros (Athens, Greece), M. Kreuter (Heidelberg, Germany), A. Tzouvelekis (Athens, Greece)

Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Session: Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Session type: E-poster session
Number: 720
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Karampitsakos (Athens, Greece), S. Torrisi (Heidelberg, Germany), K. Antoniou (Heraklion, Greece), E. Bouros (Athens, Greece), I. Korbila (Athens, Greece), E. Manali (Athens, Greece), E. Vasarmidi (Heraklion, Greece), D. Papakosta (Thessaloniki, Greece), K. Domvri (Thessaloniki, Greece), Z. Daniil (Larissa, Greece), I. Dimeas (Larissa, Greece), P. Kirgou (Larissa, Greece), I. Papanikolaou (Corfu, Greece), E. Bibaki (Heraklion, Greece), K. Markopoulou (Thessaloniki, Greece), G. Kounti (Thessaloniki, Greece), E. Tsapakidou (Thessaloniki, Greece), E. Papadopoulou (Thessaloniki, Greece), S. Papiris (Athens, Greece), D. Bouros (Athens, Greece), M. Kreuter (Heidelberg, Germany), A. Tzouvelekis (Athens, Greece). Increased monocyte count and red cell distribution width represent negative prognostic markers in patients with Idiopathic Pulmonary Fibrosis.. 720

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased monocyte count and red cell distribution width represent negative prognostic markers in patients with Hypersensitivity Pneumonitis
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020


Blood monocyte counts as a potential prognostic marker for idiopathic pulmonary fibrosis: analysis from the Australian IPF registry
Source: Eur Respir J, 55 (4) 1901855; 10.1183/13993003.01855-2019
Year: 2020



Prognostic value of red cell distribution width in patients with pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012

Lymphocyte to monocyte ratio (LMR) predicts survival in patients with Idiopathic Pulmonary Fibrosis (IPF).
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021


Expression of macrophage migration inhibitory factor in patients with idiopathic pulmonary fibrosis
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Elevated leukocyte count predicts survival in patients with idiopathic pulmonary fibrosis: analysis from the Swedish and Japanese cohorts
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021


Association between leukocyte telomere length (LTL) and functional decline in patients with Idiopathic Pulmonary Fibrosis (IPF) on antifibrotic treatment
Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia
Year: 2019



Red cell distribution width (RDW) as a biomarker of disease severity in ILD patients
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015

The role of monocyte count on monitoring patients with Idiopatic Pulmonary Fibrosis  under antifibrotic treatment
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020


Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Blood leukocyte levels as potential prognostic markers in IPF
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
Year: 2021


Importance of meanplatelet volume, platelet distribution width and red blood cell distribution width in asthmatic subjects
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015


Increased fraction of small round lymphocyte in BALF is a diagnostic indicator for sarcoidosis
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020


Distinct gene expression profiles of cultured stromal cells from the patients with idiopathic pulmonary fibrosis and lung adenocarcinoma
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015

The prognostic value of  Red cell distribution width(RDW) in acute pulmonary thromboembolism
Source: International Congress 2018 – Acute pulmonary embolism: from diagnosis to treatment
Year: 2018

Altered expression of adhesion molecules in circulating neutrophils of patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 479s
Year: 2002

Pulmonary expression of alternatively spliced tissue factor as a potential prognostic marker in idiopathic pulmonary fibrosis
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

Prognostic significance of neutrophils, lymphocytes and fibroblast foci in idiopathic pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 396s
Year: 2006

Late Breaking Abstract - Prognostic value of serum biomarkers in patients with idiopathic pulmonary fibrosis and correlation with disease progression.
Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases
Year: 2021


Role of macrophage activation in type II alveolar cells transplantation for the treatment of idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013